Relay Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 5 published signal records.
Relay Therapeutics last closed at $17.41 (-3.01%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -12.3×. Its overall grade ranks 163 of 738 stocks in Healthcare.
About this company
Relay Therapeutics last closed at $17.41 (-3.01%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 163/738
Valuation grade B+
Related stocks
- RocheCustomer
디그레이더/항암 신약 공동개발·라이선스 파트너로 연결
- GenentechCustomer
릴레이의 주요 항암 프로그램과 협업 이력으로 연결된 파트너
- PfizerCompetitor
표적항암·정밀의학 분야에서 신약 개발 경쟁
About Relay Therapeutics
- What technical signals does Relay Therapeutics (RLAY) have?
- Relay Therapeutics current technical signals: no active technical signal.
- Is Relay Therapeutics a cup-and-handle pattern?
- No. Relay Therapeutics has no valid Cup signal right now.
- What published figures are available for Relay Therapeutics?
- Market cap: $3.02B. Trailing 12 months PER: -12.3×. Latest quarter PBR: 3.97×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Relay Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.